Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avalo Therapeutics Inc

4.78
+0.02000.42%
Post-market: 5.010.2300+4.81%18:09 EDT
Volume:93.80K
Turnover:443.78K
Market Cap:51.76M
PE:-0.97
High:4.85
Open:4.78
Low:4.55
Close:4.76
Loading ...
Jul 11, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Jul 09, 2024

Major Issues Report

Form 8-K - Current report
Jun 24, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 24, 2024

Major Issues Report

Form 8-K - Current report
Jun 24, 2024

Major Issues Report

Form 8-K - Current report
Jun 03, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2024

Major Issues Report

Form 8-K - Current report
Apr 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 05, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 31, 2024

Major Issues Report

Form 8-K - Current report